Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118430) titled 'Clinical study on the treatment of erythropoiesis-stimulating agent (ESA) hyporesponse anemia in CKD patients with Pegmolesatide' on Feb. 5.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First People's Hospital of Lianyungang
Condition:
Chronic kidney diseases
Intervention:
Pegmolesatide group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-09-10
Target Sample Size: Pegmolesatide group:15;Roxadustat group:15;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=293427
Published by HT Digit...